Abstract:Celiac disease (CD) is a common systemic disorder that results from an abnormal response of human immunity to gluten intake, affecting the small intestine. In individuals who carry a genetic susceptibility, CD is triggered by environmental factors, including viral infections and dysbiosis of the gut microbiota. The gut microbiome is essential in controlling the immune system, and recent findings indicate that changes in the gut microbiome may contribute to various chronic immune disorders, such as CD through mechanisms that still require further exploration. Some bacteria exhibit epitopes that mimic gliadin and may enhance an immune response in the host. Other bacteria, including Pseudomonas aeruginosa, may work in conjunction with gluten to trigger and escalate intestinal inflammation. The microbiota may also directly influence antigen development through the production of immunogenic or tolerogenic gluten peptides or directly influence intestinal permeability through the release of zonulin. Finally, the gut microbiome can impact intestinal inflammation by generating proinflammatory or anti-inflammatory cytokines and metabolites. It is crucial to consider the impact of genetic factors (specifically, HLA-DQ haplotypes), perinatal elements such as birth mode, type of infant feeding, and antibiotic and infection exposure on the composition of the early intestinal microbiome. According to the available studies, the gut microbiome alterations associated with CD tend to exhibit a decreased presence of beneficial bacteria, including some anti-inflammatory Bifidobacterium species. However, some controversy remains as some reports have found no significant differences between the gut microbiomes of individuals with and without CD. A better understanding of the gut microbiome's role in the development of CD would greatly benefit both prevention and treatment efforts, especially in complicated or treatment-resistant cases. Here, we have attempted to summarize the available evidence on the relationship between the gut microbiota and CD, with a particular focus on potential therapeutic targets.

Life-threatening onset of coeliac disease: a case report and literature review

Celiac Disease and Neurological Manifestations: From Gluten to Neuroinflammation

Celiac Disease Presenting as Hemorrhagic Shock: a Rare Complication

Celiac Disease: A Forty-Year Analysis in an Italian Referral Center

Clinical presentation of celiac disease in adult patients: current real-life experience

Coeliac disease in childhood: An overview

Refractory celiac disease and its mimickers: a review on pathogenesis, clinical-pathological features and therapeutic challenges

Navigating coeliac disease diagnosis in primary care

Gastrointestinal and Hepatobiliary Manifestations Associated with Untreated Celiac Disease in Adults and Children: A Narrative Overview

'It was hell on earth': perspectives of people living with celiac disease on diagnostic delay

Review on pediatric coeliac disease from a clinical perspective

Guidelines for best practices in monitoring established coeliac disease in adult patients

New entity of adult ultra-short coeliac disease: the first international cohort and case–control study

Extra-digestive manifestations of celiac disease

Updates in the diagnosis and management of coeliac disease

Effect of Gluten-Free Diet on Gut Microbiota Composition in Patients with Celiac Disease and Non-Celiac Gluten/Wheat Sensitivity

Interaction between Gut Microbiota and Celiac Disease: From Pathogenesis to Treatment

Evolution in coeliac disease diagnosis and management

An updated overview on celiac disease: from immuno-pathogenesis and immuno-genetics to therapeutic implications